(Q80089099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

A pravastatin dose-escalation study in systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

28 December 2019

main subject

0 references

7

Elizabeth W Karlson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

Karen H Costenbader

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

3

Lori B Chibnik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Matthew H Liang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Juliet Aizer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hannah Kwon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Victoria Gall

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

3 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1071-1077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404733%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-007-0341-6

28 December 2019

exact match

0 references

cites work

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

1 reference

12 December 2020

How to improve morbidity and mortality in systemic lupus erythematosus

1 reference

12 December 2020

Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease

1 reference

12 December 2020

Drug treatment of lipid disorders

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

12 December 2020

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

12 December 2020

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

1 reference

12 December 2020

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

12 December 2020

Measurement of systemic lupus erythematosus activity in clinical research

1 reference

12 December 2020

Pravastatin Therapy and the Risk of Stroke

1 reference

12 December 2020

Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus

1 reference

12 December 2020

Current perspectives on statins

1 reference

12 December 2020

Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone

1 reference

12 December 2020

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

12 December 2020

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

12 December 2020

A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus

1 reference

12 December 2020

Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management

1 reference

12 December 2020

Clinically relevant differences between the statins: implications for therapeutic selection

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Risks and benefits of statins in lupus erythematosus

1 reference

12 December 2020

Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis

1 reference

12 December 2020

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

1 reference

12 December 2020

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome

1 reference

12 December 2020

Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression

1 reference

12 December 2020

Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population

1 reference

12 December 2020

Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation

1 reference

12 December 2020

Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).

1 reference

12 December 2020

The evolving role of statins in the management of atherosclerosis

1 reference

12 December 2020

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

1 reference

12 December 2020

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

12 December 2020

Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?

1 reference

12 December 2020